Becton, Dickinson and Company (BDX)
BDX Launches AI-Enabled Platform to Unify Healthcare Connectivity
BD's new AI-driven Incada Platform and upgraded Pyxis Pro system unite connected care, driving its digital healthcare edge.
BD Stock Down Despite Making Progress in the Treatment of PAD Lesions
BDX advances PAD care with first patient enrolled in the XTRACT Registry using its dual-action Rotarex system.
BD Stock Down Despite Tie-Up to Boost Single-Cell Sequencing Workflow
BDX teams with Opentrons to automate single-cell sequencing, advancing its multiomics and biosciences strategy.
Why Becton Dickinson (BDX) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Becton Dickinson (BDX) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Becton Dickinson (BDX) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Becton Dickinson (BDX) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
BD Stock Gains in Pre-Market Following Q3 Earnings Beat, Margins Up
BDX tops third-quarter fiscal 2025 earnings and margin estimates, with strong results from its Medical and Interventional segments.
Here's What Key Metrics Tell Us About Becton Dickinson (BDX) Q3 Earnings
Although the revenue and EPS for Becton Dickinson (BDX) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Becton, Dickinson and Company (BDX) Q3 2025 Earnings Call Transcript
Becton, Dickinson and Company (NYSE:BDX ) Q3 2025 Earnings Call August 7, 2025 8:00 AM ET Company Participants Christopher J. DelOrefice - Executive VP & CFO Greg Rodetis - Senior VP, Treasurer & Head of Investor Relations Thomas E.
Becton Dickinson (BDX) Surpasses Q3 Earnings and Revenue Estimates
Becton Dickinson (BDX) came out with quarterly earnings of $3.68 per share, beating the Zacks Consensus Estimate of $3.42 per share. This compares to earnings of $3.5 per share a year ago.
Can Sustained Product Demand Drive BDX Stock Before Q3 Earnings?
BD's third-quarter fiscal 2025 results are likely to benefit from product launches across Medical and Interventional segments, which drive strong revenue potential.
